Q97840077
motion by Fredrik Olovsson 2007
Press Enter · cited answer in seconds
0 sources
Q97840077
Summary
Q97840077 is an individual motion[1].
Key Facts
- Q97840077 authored Fredrik Olovsson[2].
- Q97840077's instance of is recorded as individual motion[3].
- Q97840077's part of the series is recorded as motions of the 2007-2008 legislative session of the Riksdag[4].
- Q97840077's language of work or name is recorded as Swedish[5].
- Q97840077's publication date is recorded as +2007-09-21T00:00:00Z[6].
- Q97840077's main subject is recorded as medication[7].
- Q97840077's work available at URL is recorded as http://data.riksdagen.se/dokument/GV02So204[8].
- Q97840077's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GV02So204[9].
- Q97840077's applies to jurisdiction is recorded as Sweden[10].
- Q97840077's legal citation of this text is recorded as Mot. 2007/08:So204[11].
- Q97840077's title is recorded as Regler för marknadsföring av läkemedel[12].
- Q97840077's maintained by WikiProject is recorded as Project Riksdagen's documents[13].
- Q97840077's copyright status is recorded as public domain[14].
- Q97840077's legislative committee is recorded as Committee on Health and Welfare[15].
- Q97840077's Swedish Riksdag document ID is recorded as GV02So204[16].
Body
Works and Contributions
Q97840077 authored Fredrik Olovsson[2].